Anti-FcRn (Research Grade Rozanolixizumab Biosimilar) sinobiological 68134-H001
| Catalog No. | Size | Price (USD) |
| 68134-H001-5 | 5 mg | $740.55 |
| 68134-H001-25 | 25 mg | $2,221.66 |
| 68134-H001-500 | 500 µg | $222.17 |
| Catalog No. | Size | Price (USD) |
| 68134-H001-5 | 5 mg | $740.55 |
| 68134-H001-25 | 25 mg | $2,221.66 |
| 68134-H001-500 | 500 µg | $222.17 |
General Information
| Product name | Anti-FcRn (Research Grade Rozanolixizumab Biosimilar) |
| Species reactivity | Reacts with: Human |
| Specificity | FcRn |
| Preparation | This product is a recombinant monoclonal antibody expressed from HEK293 cells. |
| Source | IgG4, Kappa |
| Purification | Protein A |
| Formulation | Histidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80, pH6.0 |
| Conjugate | Unconjugated |
| Endotoxin | ≦ 1 EU/mg |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Image / Experimental Information
| Image 1 Description | ≥95 % as determined by SDS-PAGE. |
| Image 1 Alt Text | Human FcRn-Rozanolixizumab Enzyme linked immunosorbent assay (ELISA) 46043 |
| Image 1 URL | Source image |
| Image 2 Description | ≥95 % as determined by SDS-PAGE. |
| Image 2 Alt Text | Human FcRn-Rozanolixizumab Enzyme linked immunosorbent assay (ELISA) 46044 |
| Image 2 URL | Source image |
title: Enhanced ADCC Activity of a C-Terminal Lysine Variant of an IgG 1 Antibody Driven by N-Linked MAN5 Glycan Using a Reporter Gene Assay
authors: Ming-Ching Hsieh; Kristiina Dorofejeva; ...; Babita S. Parekh
journal: Antibodies
date: 2025-10-17
pmid: 41133683
doi: 10.3390/antib14040089
cited_by_count: 0
techniques: Concentration Assay; Produced
bioz_score: 93
title: Bispecific antibody specifically binding to IL-17A and TNF-α
authors: Jae Bong Yoon; Eun Young Jeon; ...; Young Woo Park
date: 2024-11-12
cited_by_count: 0
techniques: Binding Assay; Residue
bioz_score: 92
title: Preclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors
authors: Chenfei Zhou; Jinling Jiang; ...; Jun Zhang
journal: Experimental hematology & oncology
date: 2024-10-01
doi: 10.1186/s40164-024-00567-7
pmcid: 11443874
cited_by_count: 0
techniques: Binding Assay; Recombinant; Software
bioz_score: 93
title: Characterization of Neutralizing Human Anti-Tetanus Monoclonal Antibodies Produced by Stable Cell Lines.
authors: Tania Maria Manieri; Daniela Yumi Takata; ...; Ana Maria Moro
journal: Pharmaceutics
date: 2022-09-20
pmid: 36297421
cited_by_count: 4
techniques: Binding Assay
bioz_score: 93
title: Influence of the bispecific antibody IgG subclass on T cell redirection.
authors: Stephanie Kapelski; Erna Cleiren; ...; Mark L Chiu
journal: mAbs
date: 2020-01-30
pmid: 31242061
cited_by_count: 9
techniques: Binding Assay; Cell Culture; Cell Isolation; Competitive Binding Assay; Flow Cytometry; Gradient Centrifugation; Incubation; Isolation; Labeling; Magnetic Cell Separation; Selection; Serial Dilution
bioz_score: 93